Sarepta Therapeutics' Route 79 program awards up to $5,000 each to as many as 20 students with Duchenne muscular dystrophy and 5 siblings of someone with Duchenne, to be used for tuition, fees, books, and supplies at a college, university, or trade or technical school in the U.S. High school seniors and current undergraduates accepted to or enrolled in an eligible program are eligible. The program is administered independently by ISTS, and recipients are chosen based on an essay, community involvement, and academic achievement.
DemographicsMust be diagnosed with Duchenne muscular dystrophy, or be the sibling of someone diagnosed with Duchenne, and be a legal U.S. resident.